FIELD: chemistry.
SUBSTANCE: invention relates to heterocyclic compounds of formula I
, where Y denotes -(C=O)-, X denotes -N(R10)-, A denotes -C(A1)(A2)-, B denotes O, S, -(C=O)- or is characterised by formula
, where D denotes N or CR10, and where the remaining substitutes are described in the claim. Compounds of formula I, as well as composition based on said compounds can inhibit the bcl-2 family proteins.
EFFECT: possibility of using said compounds and compositions in treating or modulating disorders associated with hyper-proliferation, such as cancer.
20 cl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS | 2005 |
|
RU2416606C2 |
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
CYCLOPAMINE ANALOGUES AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2403256C2 |
SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2428424C2 |
Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER | 2010 |
|
RU2555326C2 |
FGFR AND ITS MUTATION INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2811207C1 |
SUBSTITUTED NICOTINAMIDES AS KCNQ2-3 MODULATORS | 2010 |
|
RU2529904C2 |
ANTAGONISTS OF THROMBIN RECEPTOR | 2005 |
|
RU2408594C2 |
COMPLEXES | 2015 |
|
RU2682680C2 |
COMPLEXES | 2015 |
|
RU2684934C2 |
Authors
Dates
2011-07-20—Published
2006-12-15—Filed